Find Federal Grants
Zambia USAID-Lusaka · 72061120RFA00003
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
National Institutes of Health · PAR-20-152
National Institutes of Health · RFA-AI-20-020
Department of Homeland Security - FEMA · DHS-20-TTP-132-00-01
Strengthening Federal Ministry of Health Capabilities in Technical Assistance for Service Delivery and Execution of Core Public Health Functions to Achieve and Sustain HIV Epidemic Control in Ethiopia, under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2030
State Opioid Response Grants
Substance Abuse and Mental Health Services Adminis · TI-20-012
Comprehensive Suicide Prevention
Centers for Disease Control - NCIPC · CDC-RFA-CE20-2001
Centers for Disease Control - NCCDPHP · CDC-RFA-DP20-2007
Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
Centers for Disease Control - CGH · CDC-RFA-GH20-2083
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
National Institutes of Health · PAR-20-150
Centers for Disease Control and Prevention - ERA · RFA-CE-20-005
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
National Institutes of Health · RFA-ES-20-009
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed)
National Institutes of Health · PAR-20-148
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed)
National Institutes of Health · PAR-20-147
BOLD Public Health Programs to Address Alzheimer's Disease and Related Dementias
Centers for Disease Control - NCCDPHP · CDC-RFA-DP20-2004
BOLD Public Health Centers of Excellence to Address Alzheimer's Disease and Related Dementias
Centers for Disease Control - NCCDPHP · CDC-RFA-DP20-2005
Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)
National Institutes of Health · RFA-DA-21-005
Assistant Secretary for Preparedness and Response · EP-U3R-20-001
Strengthening Access to and Delivery of Quality Public Health Services for Prevention, Care and Treatment of HIV, STIs, and TB, Addressing Diseases of Public Health Importance, and Advancing Global Health Security in Jamaica under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2136
National Institutes of Health · PA-20-146